Our company is the first CRO conducting clinical studies of nutritional products in Russia in compliance with ICH-GCP. OCT has made the nutrition trial with 650 patients enrolled for one of the world famous health food manufactures.
Consumption of nutraceuticals is progressively increasing now. What consumers need most, are safe products with demonstrated effects on body function.
Clinical validation is an essential and critical priority for nutraceuticals. Safety and clinical nutraceutical activity are definite consumer concerns. Increasingly more companies are responding by sponsoring scientifically sound, publishable clinical studies.
Companies can gain the trust of consumers by providing sound science based research data, documenting safety, assuring product integrity, and by never misleading consumers.
Clinical trials of nutraceutical products guarantee its’ manufactures better reputation resulting in more profits for the companies, from one hand; safety and efficacy of such products for the consumers, from another hand.
Furthermore, numerous clinical studies have demonstrated impressive benefits from nutritional supplementation. It is now well established that nutritional factors are of major importance in the pathogenesis of both arteriosclerosis and cancer, the two leading causes of death in the developed countries. A lot of studies have demonstrated the role of trace mineral deficiency in conditions as varied as asthma, hyperactivity, migraine, acne, chronic fatigue syndrome, rheumatoid arthritis, osteoarthritis, hypertension, kidney stones and premenstrual syndrome, others.
